Acelyrin, Inc.
SLRN
$2.12
-$0.05-2.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.09% | -25.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 67.80% | -52.77% | |||
| Operating Income | -67.80% | 52.77% | |||
| Income Before Tax | -62.79% | 43.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -62.79% | 43.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -62.79% | 43.33% | |||
| EBIT | -67.80% | 52.77% | |||
| EBITDA | -67.87% | 52.82% | |||
| EPS Basic | -62.06% | 43.72% | |||
| Normalized Basic EPS | -6.43% | 56.24% | |||
| EPS Diluted | -62.06% | 43.72% | |||
| Normalized Diluted EPS | -6.43% | 56.24% | |||
| Average Basic Shares Outstanding | 0.45% | 0.68% | |||
| Average Diluted Shares Outstanding | 0.45% | 0.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||